A cost-utility analysis of clopidogrel in patients with non-ST-segment-elevation acute coronary syndromes in the UK

This publication has 22 references indexed in Scilit:

• Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
  European Heart Journal, 2002
• Management of acute coronary syndromes. Variations in practice and outcome. Findings from the Global Registry of Acute Coronary Events (GRACE)
  European Heart Journal, 2002
• Incidence and case fatality rates of stroke subtypes in a multiethnic population: the South London Stroke Register
  Journal of Neurology, Neurosurgery & Psychiatry, 2002
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
  BMJ, 2002
• Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation
  New England Journal of Medicine, 2001
• Guideline for the management of patients with acute coronary syndromes without persistent ECG ST segment elevation
  Heart, 2001
• The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme. Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease
  European Heart Journal, 2000
• Clinical outcomes, risk stratification and practice patterns of unstable angina and myocardial infarction without ST elevation: Prospective Registry of Acute Ischaemic Syndromes in the UK (PRAIS-UK)
  Published by Oxford University Press (OUP) ,2000
• Cost-Effectiveness Analysis of Antiplatelet Therapy in the Prevention of Recurrent Stroke in the UK
  PharmacoEconomics, 1999
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
  The Lancet, 1996